Avadel Pharmaceuticals PLC (AVDL) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $21.64
• Market Cap: $2.12B
• 52-Week High: $23.57
• 52-Week Low: $6.38

Market Sentiment

Avadel Pharmaceuticals PLC currently has a Neutral sentiment score of -0.10.

About Avadel Pharmaceuticals PLC

Avadel Pharmaceuticals PLC is a Dublin-based biopharmaceutical company focused on developing innovative therapies for rare and complex conditions, particularly in sleep medicine and endocrine disorders. Leveraging its expertise in drug formulation and delivery, Avadel is committed to addressing significant unmet medical needs with its differentiated product pipeline. The company is well-positioned for growth in the dynamic biopharmaceutical landscape, actively pursuing strategic partnerships ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Avadel Pharmaceuticals PLC and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does AVDL pay dividends?

Avadel Pharmaceuticals PLC (AVDL) does not currently pay a regular dividend.

What is AVDL's market cap?

Avadel Pharmaceuticals PLC (AVDL) has a market capitalization of $2.12B with a current stock price of $21.64.